Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 8.6T | 9.0T | 8.3T | 8.6T |
Cost of revenue | 3.3T | 3.3T | 2.9T | 3.0T |
Gross profit | 5.3T | 5.7T | 5.4T | 5.6T |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | 427.9B | 581.1B | 567.5B | 604.6B |
Other operating expenses | 31.0B | 42.0B | 30.4B | 31.2B |
Operating income | 1.4T | 1.5T | 1.3T | 1.4T |
Non operating interest income | ||||
Income | 31.9B | 22.8B | 25.2B | 16.6B |
Expense | 763.8B | 795.0B | 754.4B | 770.7B |
Other income expense | — | — | — | — |
Pretax income | 523.2B | 673.3B | 415.6B | 661.1B |
Tax provision | 134.9B | 160.6B | 117.8B | 171.4B |
Net income | 388.2B | 512.7B | 297.8B | 489.7B |
Basic EPS | 29 | — | — | — |
Diluted EPS | 29 | — | — | — |
Basic average shares | 239.5T | — | — | — |
Diluted average shares | 239.5T | — | — | — |
EBITDA | 4.2T | 4.4T | 4.1T | 4.4T |
Net income from continuing op. | — | — | — | — |
Minority interests | -3.7B | -10.4B | -6.0B | -3.9B |
Preferred stock dividends | 0 | 0 | 0 | 0 |